HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 14 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $617,000 | -23.1% | 271,893 | -7.8% | 0.00% | 0.0% |
| Q2 2016 | $802,000 | -31.0% | 294,755 | -27.2% | 0.00% | 0.0% |
| Q1 2016 | $1,162,000 | -42.5% | 404,826 | -12.6% | 0.00% | -50.0% |
| Q4 2015 | $2,020,000 | -42.8% | 463,200 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $3,530,000 | -31.7% | 463,200 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $5,165,000 | – | 463,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |